
Brian S Kim MD MTR, FAAD
Sol and Clara Kest Professor, Vice Chair of Research, Site Chair, and Director of the Mark Lebwohl Center for Neuroinflammation and Sensation
Join to View Full Profile
1425 Madison AveNew York, NY 10029
Phone+1 314-659-1711
Dr. Kim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Kim is a highly experienced Dermatologist based in New York, NY. Completing his medical degree and two residencies at the University of Washington, he continued his education at the Perelman School of Medicine at the University of Pennsylvania and the University of Pennsylvania School of Medicine. Dr. Kim has held multiple prestigious current and past positions, including Professor at Icahn School of Medicine, Co-Director and Associate Professor of Medicine at Washington University in St. Louis School of Medicine, and Clinical Instructor at Perelman School of Medicine. His areas of expertise include atopic dermatitis, pruritus, innate immunity, and neuroimmunology. He has several noteworthy publications, clinical trials, and awards under his belt. Notably, he's been recognized with awards such as the Young Dermatologist Achievement Award and the Young Leadership Award among others.
Education & Training
University of Pennsylvania School of MedicineMTR, 2012 - 2014
Perelman School of Medicine at the University of PennsylvaniaPost-Doctoral Fellowship, 2010 - 2014
University of Pennsylvania Health SystemResidency, Dermatology, 2008 - 2011
University of WashingtonResidency, Internal Medicine, 2007 - 2008
University of Washington School of MedicineClass of 2007, MD, Alpha Omega Alpha
Certifications & Licensure
FL State Medical License 2023 - 2028
NY State Medical License 2022 - 2027
CA State Medical License 2020 - 2026
MO State Medical License 2014 - 2022
OK State Medical License 2020 - 2020
PA State Medical License 2008 - 2014
NJ State Medical License 2010 - 2011
American Board of Dermatology Dermatology- Join now to see all
Awards, Honors, & Recognition
- Young Leardership Award American Dermatological Association, 2019
- Young Dermatologist Achievement Award International League of Dermatological Societies, 2019
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014, 2016-2017
Clinical Trials
- Open-label Study of Dupilumab in Patients With Atopic Dermatitis Start of enrollment: 2013 Oct 10
- Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis Start of enrollment: 2013 Dec 10
- A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Dupilumab subgroup responder analysis: aanalysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.Brian S Kim, Shawn G Kwatra, Gil Yosipovitch, Sonja Ständer, Sarina B Elmariah
The Journal of Dermatological Treatment. 2026-12-01 - IL-13 signaling in cDC2 is required for systemic anaphylactic responses.Yasuyo Harada, Takanori Sasaki, Kazushige Obata-Ninomiya, Takahiro Matsuyama, Satoshi Ueha
Proceedings of the National Academy of Sciences of the United States of America. 2026-07-14 - Induction of human pruriceptors from pluripotent stem cells via transcription factors.Hisato Iriki, Ruiqi Hu, Xu Li, Erdene Baljinnyam, Carina Habich
Stem Cell Reports. 2026-07-09
Journal Articles
- Innate Lymphoid Cells in the SkinKim BS, J Invest Dermatol, 10/23/2014
Press Mentions
Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin BiologyApril 3rd, 2023
Notalgia Paresthetica: Difelikefalin Helps Upper-Back Itch, but with Side EffectsFebruary 13th, 2023
Difelikefalin Improves Itch Intensity in Notalgia ParestheticaFebruary 10th, 2023
Grant Support
- Mentored Clinical Scientist Development K08 AwardNational Institute of Arthritis and Musculoskeletal and Skin Diseases2014–Present
- NIH Research Project Grant (R01)National Institute of Arthritis and Musculoskeletal and Skin Diseases2016–2021
- Clinical Scientist Development AwardDoris Duke Charitable Foundation2016–2019
- NIH CTSA AwardNational Institutes of Health2012–2014
- Skin Disease Research Center Pilot and Feasibility GrantNational Institute of Arthritis and Musculoskeletal and Skin Diseases2011–2012
Research History
- Postdoctoral Fellow/Laboratory of David ArtisIn the Artis Lab, I identified previously unrecognized group 2 innate lymphoid cells (ILC2s) in the skin of both mice and humans, and their critical role in atopic dermatitis. Following up on this project, I found that basophils regulate ILC2 responses in this context as well.2010 - 2014
- Research Fellow/Laboratory of Stephen I. KatzIn the Katz Lab, I investigated the mechanisms that underlie skin inflammation in the context of graft-versus-host disease (GvHD). Unexpectedly, I identified that keratinocytes could act as accessory cells for the presentation of keratinocyte-derived antigen.2004 - 2006
Professional Memberships
- Member
External Links
- Kim Lab Websitehttps://www.briankimlab.org
- Center for the Study of Itch and Sensory Disordershttp://csi.wustl.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










